Biology of Blood and Marrow Transplantation
Volume 13, Issue 1 , Pages 1-25 , January 2007

The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Myeloid Leukemia in Children: An Evidence-Based Review

  • Denise M. Oliansky

      Affiliations

    • Roswell Park Cancer Institute, Buffalo, New York
    • ,
  • J. Douglas Rizzo

      Affiliations

    • Medical College of Wisconsin, Milwaukee, Wisconsin
    • ,
  • Peter D. Aplan

      Affiliations

    • NIH, NCI, CCR, Genetics Branch, Bethesda, Maryland
    • ,
  • Robert J. Arceci

      Affiliations

    • Kimmel Comprehensive Cancer Center, Baltimore, Maryland
    • ,
  • Louis Leone

      Affiliations

    • Children’s Oncology Group, Arcadia, California
    • ,
  • Yaddanapudi Ravindranath

      Affiliations

    • Childrens’s Hospital of Michigan and Wayne State University School of Medicine, Detroit, Michigan
    • ,
  • Jean E. Sanders

      Affiliations

    • Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington
    • ,
  • Franklin O. Smith III

      Affiliations

    • Cincinnati Children’s Hospital and Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio
    • ,
  • Fiona Wilmot

      Affiliations

    • Blue Shield of California, San Francisco, California
    • ,
  • Philip L. McCarthy Jr

      Affiliations

    • Roswell Park Cancer Institute, Buffalo, New York
    • ,
  • Theresa Hahn

      Affiliations

    • Roswell Park Cancer Institute, Buffalo, New York
    • Corresponding Author InformationCorrespondence and reprint requests: Theresa Hahn, PhD, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263.

Received 20 October 2006 ,Accepted 23 October 2006.

References 

  1. Hahn T, Wolff SN, Czuczman M, et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin’s lymphoma: an evidence-based review. Biol Bone Marrow Transplant. 2001;7:308–331
  2. Hahn T, Wingard JR, Anderson KC, et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidence-based review. Biol Bone Marrow Transplant. 2003;9:4–37
  3. Hahn T, Wall D, Camitta B, et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in children: an evidence-based review. Biol Bone Marrow Transplant. 2005;11:823–861
  4. Hahn T, Wall D, Camitta B, et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review. Biol Bone Marrow Transplant. 2006;12:1–30
  5. Bourquin JP, Thornley I, Neuberg D, et al. Favorable outcome of allogeneic hematopoietic stem cell transplantation for relapsed or refractory acute promyelocytic leukemia in childhood. Bone Marrow Transplant. 2004;34:795–798
  6. Classen C, Debatin K, Friedrich W, et al. Long-term remission of APL with a second allogeneic BMT after CNS relapse following HLA-identical allogeneic BMT. Bone Marrow Transplant. 2003;32:843–846
  7. Grimwade D, Jamal R, Goulden N, et al. Salvage of patients with acute promyelocytic leukaemia with residual disease following ABMT performed in second CR using all-trans retinoic acid. Br J Haematol. 1998;103:559–562
  8. Quah TC, Yeoh AE, Sun L. Autologous bone marrow transplantation in a child with acute promyelocytic leukemia in second remission. Singapore Med J. 1997;38:344–346
  9. Grupp SA, Frangoul H, Wall D, et al. Use of G-CSF in matched sibling donor pediatric allogeneic transplantation: a consensus statement from the Children’s Oncology Group (COG) Transplant Discipline Committee and Pediatric Blood and Marrow Transplant Consortium (PBMTC) Executive Committee. Pediatr Blood Cancer. 2006;46:414–421
  10. Pulsipher MA, Nagler A, Iannone R, et al. Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors. Pediatr Blood Cancer. 2006;46:422–433
  11. Alonzo TA, Wells RJ, Woods WG, et al. Postremission therapy for children with acute myeloid leukemia: the children’s cancer group experience in the transplant era. Leukemia. 2005;19:965–970
  12. Woods WG, Neudorf S, Gold S, et al. A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission. Blood. 2001;97:56–62
  13. Ravindranath Y, Yeager AM, Chang MN, et al. Pediatric Oncology Group Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. N Engl J Med. 1996;334:1428–1434
  14. Stevens RF, Hann IM, Wheatley K, et al. MRC Childhood Leukaemia Working Party Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council’s 10th AML trial. Br J Haematol. 1998;101:130–140
  15. Amadori S, Testi AM, Arico M, et al. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. J Clin Oncol. 1993;11:1046–1054
  16. Pession A, Rondelli R, Basso G, et al. Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocols. Leukemia. 2005;19:2043–2053
  17. Wells RJ, Woods WG, Buckley JD, et al. Treatment of newly diagnosed children and adolescents with acute myeloid leukemia: a Childrens Cancer Group study. J Clin Oncol. 1994;12:2367–2377
  18. Nesbit ME, Buckley JD, Feig SA, et al. Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group. J Clin Oncol. 1994;12:127–135
  19. Perel Y, Auvrignon A, Leblanc T, et al. Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit-multi center studies of the French LAME Cooperative Group. Leukemia. 2005;19:2082–2089
  20. Michel G, Leverger G, Leblanc T, et al. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission (A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP)). Bone Marrow Transplant. 1996;17:191–196
  21. Lie S, Abrahamsson J, Clausen N, et al. Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down’s syndrome: results of NOPHO-AML trials. Br J Haematol. 2003;122:217–225
  22. Entz-Werle N, Suciu S, van der Werff ten Bosch J, et al. Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children’s Leukemia Group report. Leukemia. 2005;19:2072–2081
  23. Liang D, Chang TT, Lin KH, et al. Improved treatment results for childhood acute myeloid leukemia in Taiwan. Leukemia. 2006;20:136–141
  24. Dahl G, Kalwinsky D, Mirro J, et al. Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission. J Clin Oncol. 1990;8:295–303
  25. Lange B, Dinndorf P, Smith F, et al. Pilot study of idarubicin-based intensive-timing induction therapy for children with previously untreated acute myeloid leukemia: Children’s Cancer Group Study 2941. J Clin Oncol. 2004;22:150–156
  26. Wells R, Adams M, Alonzo T, et al. Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children’s Cancer Group Study 2951. J Clin Oncol. 2003;21:2940–2947
  27. Gorin NC, Labopin M, Fouillard L, et al. Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia (A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT)). Bone Marrow Transplant. 1996;18:111–117
  28. O’Brien TA, Russell SJ, Vowels MR, et al. Results of consecutive trials for children newly diagnosed with acute myeloid leukemia from the Australian and New Zealand Children’s Cancer Study Group. Blood. 2002;100:2708–2716
  29. Woods WG, Kobrinsky N, Buckley J, et al. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study. J Clin Oncol. 1993;11:1448–1457
  30. Matsuzaki A, Eguchi H, Ikuno Y, et al. Treatment of childhood acute myelogenous leukemia with allogeneic and autologous stem cell transplantation during the first remission: a report from the Kyushu-Yamaguchi Children’s Cancer Study group in Japan. Pediatr Hematol Oncol. 2000;17:623–634
  31. Matsuyama T, Horibe K, Kato K, et al. Bone marrow transplantation for children with acute myelogenous leukaemia in the first complete remission. Eur J Cancer. 2000;36:368–375
  32. Ortega JJ, Diaz de Heredia C, Olive T, et al. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children (Towards a risk-oriented therapy). Haematologica. 2003;88:290–299
  33. Creutzig U, Zimmermann M, Ritter J, et al. Definition of a standard-risk group in children with AML. Br J Haematol. 1999;104:630–639
  34. Pession ARR, Paolucci P, Pastore G, et al. Hematopoeitic stem cell transplantation in childhood: report from the bone marrow transplantation group of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP). Haematologia. 2000;85:638–646
  35. Anak S, Saribeyoglu ET, Bilgen H, et al. Allogeneic versus autologous versus peripheral stem cell transplantation in CR1 pediatric AML patients: a single center experience. Pediatr Blood Cancer. 2005;44:654–659
  36. Aladjidi N, Auvrignon A, Leblanc T, et al. Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology. J Clin Oncol. 2003;21:4377–4385
  37. Godder K, Eapen M, Laver JH, et al. Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysis. J Clin Oncol. 2004;22:3798–3804
  38. Krance RA, Hurwitz CA, Head DR, et al. Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseases. J Clin Oncol. 2001;19:2804–2811
  39. Kang HJ, Shin HY, Choi HS, et al. Autologous peripheral blood stem cell transplantation with BCVAC conditioning in childhood acute myeloid leukemia. Bone Marrow Transplant. 2004;33:471–476
  40. Horikoshi Y, Mimaya J, Amano K, et al. Feasibility study of autologous peripheral blood stem cell transplantation for the treatment of childhood acute myelogenous leukemia. Jpn J Clin Oncol. 2000;30:137–145
  41. Tiedemann K, Waters KD, Tauro GP, et al. Results of intensive therapy in childhood acute myeloid leukemia, incorporating high-dose melphalan and autologous bone marrow transplantation in first complete remission. Blood. 1993;82:3730–3738
  42. Bonetti F, Zecca M, Pession A, et al. The Italian Association for Pediatric Hematology and Oncology-Bone Marrow Transplantation Group Total-body irradiation and melphalan is a safe and effective conditioning regimen for autologous bone marrow transplantation in children with acute myeloid leukemia in first remission. J Clin Oncol. 1999;17:3729–3735
  43. Locatelli F, Rocha V, Chastang C, et al. Eurocord-Cord Blood Transplant Group Factors associated with outcome after cord blood transplantation in children with acute leukemia. Blood. 1999;93:3662–3671
  44. Nemecek ER, Gooley TA, Woolfrey AE, et al. Outcome of allogeneic bone marrow transplantation for children with advanced acute myeloid leukemia. Bone Marrow Transplant. 2004;34:799–806
  45. Neudorf S, Sanders J, Kobrinsky N, et al. Allogeneic bone marrow transplantation for children with acute myelocytic leukemia in first remission demonstrates a role for graft versus leukemia in the maintenance of disease-free survival. Blood. 2004;103:3655–3661
  46. Michel G, Gluckman E, Blaise D, et al. Improvement in outcome for children receiving allogeneic bone marrow transplantation in first remission of acute myeloid leukemia: a report from the Groupe d’Etude des Greffes de Moelle Osseuse. J Clin Oncol. 1992;10:1865–1869
  47. Dini G, Boni L, Abla O, et al. Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO) Allogeneic bone marrow transplantation in children with acute myelogenous leukemia in first remission. Bone Marrow Transplant. 1994;13:771–776
  48. Robin M, Guardiola P, Dombret H, et al. Allogeneic bone marrow transplantation for acute myeloblastic leukaemia in remission: risk factors for long-term morbidity and mortality. Bone Marrow Transplant. 2003;31:877–887
  49. Michel G, Rocha V, Chevret S, et al. Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis. Blood. 2003;102:4290–4297
  50. Marks D, Bird J, Vettenranta K, et al. T cell-depleted unrelated donor bone marrow transplantation for acute myeloid leukemia. Biol Bone Marrow Transplant. 2000;6:646–653
  51. Bunin N, Aplenc R, Leahey A, et al. Outcomes of transplantation with partial T-cell depletion of matched or mismatched unrelated or partially matched related donor bone marrow in children and adolescents with leukemias. Bone Marrow Transplant. 2005;35:151–158
  52. Michel G, Gluckman E, Esperou-Bourdeau H, et al. Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total-body irradiation—a report from the Societe Francaise de Greffe de Moelle. J Clin Oncol. 1994;12:1217–1222
  53. Ayas M, Al-Seraihi A, Al-Mahr M, et al. The outcome of children with acute myeloid leukemia (AML) post-allogeneic stem cell transplantation (SCT) is not improved by the addition of etoposide to the conditioning regimen. Pediatr Blood Cancer. 2006;47:926–930
  54. Meshinchi S, Leisenring WM, Carpenter PA, et al. Survival after second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia. Biol Bone Marrow Transplant. 2003;9:706–713
  55. Hale GA, Tong X, Benaim E, et al. Allogeneic bone marrow transplantation in children failing prior autologous bone marrow transplantation. Bone Marrow Transplant. 2001;27:155–162
  56. Woodard P, Barfield R, Hale G, et al. Outcome of hematopoietic stem cell transplantation for pediatric patients with therapy-related acute myeloid leukemia or myelodysplastic syndrome. Pediatr Blood Cancer. 2005;9999:1–5
  57. Parsons SK, Gelber S, Cole BF, et al. Quality-adjusted survival after treatment for acute myeloid leukemia in childhood: A Q-TWiST analysis of the Pediatric Oncology Group Study 8821. J Clin Oncol. 1999;17:2144–2152
  58. Leung W, Hudson M, Strickland D, et al. Late effects of treatment in survivors of childhood acute myeloid leukemia. J Clin Oncol. 2000;18:3273–3279
  59. Leahey AM, Teunissen H, Friedman DL, et al. Late effects of chemotherapy compared to bone marrow transplantation in the treatment of pediatric acute myeloid leukemia and myelodysplasia. Med Pediatr Oncol. 1999;32:163–169
  60. Locatelli F, Labopin M, Ortega J, et al. Factors influencing outcome and incidence of long-term complications in children who underwent autologous stem cell transplantation for acute myeloid leukemia in first complete remission. Blood. 2003;101:1611–1619
  61. Michel G, Socie G, Gebhard F, et al. Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation—a report from the Societe Francaise de Greffe de Moelle. J Clin Oncol. 1997;15:2238–2246
  62. Wells RJ, Arthur DC, Srivastava A, et al. Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children’s Cancer Group Study 213. Leukemia. 2002;16:601–607
  63. Lie SO, Abrahamsson J, Clausen N, et al. Long-term results in children with AML: NOPHO-AML Study Group—report of three consecutive trials. Leukemia. 2005;19:2090–2100
  64. Webb D, Harrison G, Stevens R, et al. Relationships between ages at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemia. Blood. 2001;98:1714–1720
  65. Gibson BE, Wheatley K, Hann IM, et al. Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials. Leukemia. 2005;19:2130–2138
  66. Raimondi SC, Chang MN, Ravindranath Y, et al. Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative Pediatric Oncology Group study—POG 8821. Blood. 1999;94:3707–3716
  67. Chang M, Raimondi SC, Ravindranath Y, et al. Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821. Leukemia. 2000;14:1201–1207
  68. National Cancer Policy Board. Childhood Cancer Survivorship: Improving Care and Quality of Life. Washington, DC: National Academies Press; 2003;
  69. Davies SM, Ramsay NK, Weisdorf DJ. Feasibility and timing of unrelated donor identification for patients with ALL. Bone Marrow Transplant. 1996;17:737–740

 Major funding for this study was provided by the National Marrow Donor Program.

PII: S1083-8791(06)00734-8

doi: 10.1016/j.bbmt.2006.10.024

Biology of Blood and Marrow Transplantation
Volume 13, Issue 1 , Pages 1-25 , January 2007

Article Tools

* Image Usage & Resolution